Xaira Therapeutics
Develops AI models for protein and antibody drug discovery.
Company facts
- Founded
- 2023
- Employees
- 190
- Headquarters
- United States
- Type
- Private
- Funding
- Series A · $1B · 2024
Open positions
AI Scientist, Computational Protein Design
Designs and implements deep learning models to generate protein and antibody therapeutics using AI, collaborating with biologists and drug-discovery experts in a biotech startup.
AI in Residence, Computational Protein Design
The AI in Residence program at Xaira Therapeutics is a 6-12 month role for researchers to develop and deploy generative AI models for protein and antibody drug discovery. Residents work in a small cohort to build scalable ML pipelines and foundation models that directly influence therapeutic development programs.
AI Scientist Intern, Computational Protein Design
Intern developing deep learning models with PyTorch on GPUs for computational protein and antibody therapeutic design at a biotech startup.